 Print previewpersonal data approved: 2024. I. 08. | Publications |
2022
 from data base, 2023. I. 02. |
Sinkovits György, Réti Marienn, Müller Veronika, Iványi Zsolt, Gál János, Gopcsa László, Reményi Péter, Szathmáry Beáta, Lakatos Botond, Szlávik János, Bobek Ilona, Prohászka Zita Z., Förhécz Zsolt, Mező Blanka, Csuka Dorottya, Hurler Lisa, Kajdácsi Erika, Cervenak László, Kiszel Petra, Masszi Tamás, Vályi-Nagy István, Prohászka Zoltán: Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality, THROMBOSIS AND HAEMOSTASIS 122: (2) pp. 240-256.
type of document: Journal paper/Article
number of independent citations: 3
language: English
URL |
2022
from data base, 2023. I. 02. |
Lupsa Nikolett, Szegedi Ákos, Gézsi András, Vuncs Zoltán, Masszi Tamás, Mikala Gábor, Reményi Péter, Deola Sara, Prasath Lakshmanan Arun, Terranegra Annalisa, Buzás Edit Irén, Pós Zoltán: Decreased plasma level of cytokeratin 20 (KRT20) is indicative of the emergence and severity of acute GvHD irrespective to the type of organ involvement, BIOMEDICINES 10: (3) 519
type of document: Journal paper/Article
number of independent citations: 1
language: English
URL |
2021
from data base, 2023. I. 02. |
Radich J.P., Hochhaus A., Masszi T., Hellmann A., Stentoft J., Casares M.T.G., García-Gutiérrez J.V., Conneally E., le Coutre P.D., Gattermann N., Martino B., Saussele S., Giles F.J., Ross D.M., Aimone P., Li S., Titorenko K., Saglio G.: Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial, LEUKEMIA 35: (5) pp. 1344-1355.
type of document: Journal paper/Article
number of independent citations: 16
language: English
URL |
2020
from data base, 2023. I. 02. |
Kiladjian Jean-Jacques, Zachee Pierre, Hino Masayuki, Pane Fabrizio, Masszi Tamas, Harrison Claire N, Mesa Ruben, Miller Carole B, Passamonti Francesco, Durrant Simon, Griesshammer Martin, Kirito Keita, Besses Carlos, Moiraghi Beatriz, Rumi Elisa, Rosti Vittorio, Blau Igor Wolfgang, Francillard Nathalie, Dong Tuochuan, Wroclawska Monika, Vannucchi Alessandro M, Verstovsek Srdan: Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE), LANCET HAEMATOLOGY 7: (3) pp. e226-e237.
type of document: Journal paper/Article
number of independent citations: 42
language: English
URL |
2019
from data base, 2023. I. 02. |
Tordai Attila, Bors Andras, Kiss Katalin Piroska, Balassa Katalin, Andrikovics Hajnalka, Batai Arpad, Szilvasi Aniko, Rajczy Katalin, Inotai Dora, Torbagyi Eva, Lengyel Lilla, Barta Aniko, Remenyi Peter, Masszi Tamas: Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning., PLOS ONE 14: (6) e0218945
type of document: Journal paper/Article
number of independent citations: 6
language: English
URL |
2017
from data base, 2023. I. 02. |
Varga Gergely, Mikala Gábor, Kiss Katalin Piroska, Kosóczki Éva, Szabó Edit, Meggyesi Nóra, Balassa Katalin, Kövy Petra, Tegze Bálint, Szombath Gergely, Tordai Attila, Andrikovics Hajnalka, Homolya László, Masszi Tamás: Proteasome Subunit Beta Type 1 P11A polymorphism is a new prognostic marker in multiple myeloma, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 17: (11) pp. 734-742.
type of document: Journal paper/Article
number of independent citations: 5
language: English
URL |
2012
from data base, 2023. I. 02. |
Trask PC, Cella D, Besson N, Kelly V, Masszi T, Kim DW: Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia, LEUKEMIA RESEARCH 36: (4) pp. 438-442.
type of document: Journal paper/Article
number of independent citations: 33
language: English
URL |
2010
from data base, 2023. I. 02. |
Gezsi A, Budde U, Deak I, Nagy E, Mohl A, Schlammadinger A, Boda Z, Masszi T, Evan Sadler J, Bodo I: Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza, JOURNAL OF THROMBOSIS AND HAEMOSTASIS 8: (6) pp. 1273-1280.
type of document: Journal paper/Article
number of independent citations: 23
language: English
URL |
2010
from data base, 2023. I. 02. |
Saglio G, Hochhaus A, Goh YT, Masszi T, Pasquini R, Maloisel F, Erben P, Cortes J, Paquette R, Bradley-Garelik MB, Zhu C, Dombret H: Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia in Blast Phase After 2 Years of Follow-Up in a Phase 3 Study, CANCER 116: (16) pp. 3852-3861.
type of document: Journal paper/Article
number of independent citations: 90
language: English
URL |
2008
from data base, 2023. I. 02. |
Sinko J, Csomor J, Nikolova R, Lueff S, Krivan G, Remenyi P, Batai A, Masszi T: Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey, TRANSPLANT INFECTIOUS DISEASE 10: (2) pp. 106-109.
type of document: Journal paper/Article
number of independent citations: 55
language: English
URL |
| | Number of independent citations to these publications: | 274 |
|
|
Login
